Phase II Study of Paclitaxel in Combination with Mitoxantrone and Ifosfamide/Mesna for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma after Failure to Cytarabine/Cisplatin Combination

被引：0
|
作者：
Jorge E. Romaguera
M. Alma Rodriguez
Fredrick B. Hagemeister
Peter McLaughlin
Jose Rodriguez
Alejandro Preti
Anas Younes
Andreas H. Sarris
Fernando Cabanillas
机构：
[1] University of Texas M.D. Anderson Cancer Center,Department of Lymphoma
来源：
Investigational New Drugs | 1999年 / 17卷
关键词：
relapsed NHL; paclitaxel; MINT chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose: Evaluate response, duration of response, and toxicity of paclitaxel in combination with other drugs known to be effective in non-Hodgkin's lymphoma (NHL).
引用
收藏
页码：187 / 192
页数：5
相关论文
共 50 条
  • [21] Treatment of relapsing and refractory non-Hodgkin's lymphoma with a combination of dexamethasone, Ara-C, ifosfamide and cisplatin (DAIP)
    Haim, N
    BenShahar, M
    Leviov, M
    Shklar, Z
    Omer, A
    Epelbaum, R
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1217 - 1217
  • [22] Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma
    Borghaei, H
    Millenson, M
    Schilder, R
    Alden, M
    Rogatko, A
    Wang, H
    Padavic-Shaller, K
    Smith, MR
    CANCER, 2004, 101 (09) : 2034 - 2041
  • [23] Phase II results of bendamustine in combination with rituximab in relapsed indolent non-Hodgkin's lymphoma
    van der Jagt, Richard H.
    Cohen, Philip
    Cheson, Bruce D.
    Tulpule, Anil
    Herst, Jordan A.
    Lemieux, Bernard
    Schwartzberg, Lee S.
    Robinson, K. Sue
    Oliver, Jennifer W.
    Williams, Michael E.
    ANNALS OF ONCOLOGY, 2006, 17 : 200 - 200
  • [24] Combination phase I/II study of irinotecan hydrochloride (CPT-11) and carboplatin in relapsed or refractory non-Hodgkin's lymphoma
    Tobinai, K
    Hotta, T
    Saito, H
    Ohnishi, K
    Ohno, R
    Ogura, M
    Ariyoshi, Y
    Takeyama, K
    Kobayashi, T
    Ohashi, Y
    Shirakawa, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (06) : 455 - 460
  • [25] Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial
    Kambhampati, Swetha
    Fakhri, Bita
    Ai, Weiyun Z.
    Kaplan, Lawrence D.
    Tuscano, Joseph M.
    Wieduwilt, Matthew J.
    Sudhindra, Akshay
    Cavallone, Erika
    Reiner, Jesika
    Aoun, Charlie
    Castillo, Miguel
    Martinelli, Michelle
    Ta, Teresa
    Le, Diem
    Padilla, Michelle
    Crawford, Erika
    Andreadis, Charalambos B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (03): : 139 - 146
  • [26] Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma
    Leonard, JP
    Coleman, M
    Ketas, J
    Ashe, M
    Fiore, JM
    Furman, RR
    Niesvizky, R
    Shore, T
    Chadburn, A
    Horne, H
    Kovacs, J
    Ding, CL
    Wegener, WA
    Horak, ID
    Goldenberg, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5044 - 5051
  • [27] Paclitaxel and topotecan in combination with rituximab as effective salvage regimen in relapsed or refractory aggressive non-Hodgkin's lymphoma.
    Canales, MA
    Sanjurjo, MJ
    Garcia-Vela, JA
    de Paz, R
    Gracia, J
    Hernandez, D
    Bustos, JG
    Hernandez-Navarro, F
    BLOOD, 2003, 102 (11) : 289B - 289B
  • [28] Dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma: Updated results of a multicenter phase II trial.
    Mey, UJM
    Flieger, D
    Birkmann, J
    Neubauer, A
    Ho, AD
    Kaiser, U
    Wilhelm, M
    Haarmann, G
    Hahn, C
    Strehl, JW
    Glasmacher, AG
    Schmidt-Wolf, IGH
    BLOOD, 2003, 102 (11) : 300B - 301B
  • [29] Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma
    Friedberg, JW
    Neuberg, D
    Gribben, JG
    Fisher, DC
    Canning, C
    Koval, M
    Poor, CM
    Green, LM
    Daley, J
    Soiffer, R
    Ritz, J
    Freedman, AS
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (04) : 828 - 834
  • [30] DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL)
    Coleman, M
    Leonard, J
    Shuster, MW
    Kaufman, TP
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 : 41 - 45
12345